424 related articles for article (PubMed ID: 11205237)
1. Disaccordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with tamoxifen.
Liedman R; Lindahl B; Andolf E; Willen R; Ingvar C; Ranstam J
Anticancer Res; 2000; 20(6C):4889-91. PubMed ID: 11205237
[TBL] [Abstract][Full Text] [Related]
2. Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen.
Mourits MJ; Van der Zee AG; Willemse PH; Ten Hoor KA; Hollema H; De Vries EG
Gynecol Oncol; 1999 Apr; 73(1):21-6. PubMed ID: 10094875
[TBL] [Abstract][Full Text] [Related]
3. Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound.
Gerber B; Krause A; Müller H; Reimer T; Külz T; Makovitzky J; Kundt G; Friese K
J Clin Oncol; 2000 Oct; 18(20):3464-70. PubMed ID: 11032586
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.
McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF
Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294
[TBL] [Abstract][Full Text] [Related]
5. Sonohysterography for ultrasonographic evaluation of tamoxifen-associated cystic thickened endometrium.
Achiron R; Lipitz S; Sivan E; Goldenberg M; Mashiach S
J Ultrasound Med; 1995 Sep; 14(9):685-8. PubMed ID: 7500435
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of transvaginal ultrasonographic and diagnostic hysteroscopic findings in postmenopausal breast cancer patients treated with tamoxifen.
Gao WL; Zhang LP; Feng LM
Chin Med J (Engl); 2011 Aug; 124(15):2335-9. PubMed ID: 21933565
[TBL] [Abstract][Full Text] [Related]
7. Hysteroscopic assessment of menopausal breast-cancer patients taking tamoxifen; there is a bias from the mode of endometrial sampling in estimating endometrial morbidity?
Garuti G; Grossi F; Cellani F; Centinaio G; Colonnelli M; Luerti M
Breast Cancer Res Treat; 2002 Apr; 72(3):245-53. PubMed ID: 12058966
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment and prospective assessment of endometrium in menopausal women taking tamoxifen for breast cancer.
Garuti G; Grossi F; Centinaio G; Sita G; Nalli G; Luerti M
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):101-6. PubMed ID: 16678960
[TBL] [Abstract][Full Text] [Related]
9. The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Coibion M; Bianco AR;
Hum Reprod; 2005 Jan; 20(1):294-301. PubMed ID: 15513977
[TBL] [Abstract][Full Text] [Related]
10. Anastrozole versus tamoxifen treatment in postmenopausal women with endocrine-responsive breast cancer and tamoxifen-induced endometrial pathology.
Gerber B; Krause A; Reimer T; Mylonas I; Makovitzky J; Kundt G; Janni W
Clin Cancer Res; 2006 Feb; 12(4):1245-50. PubMed ID: 16489080
[TBL] [Abstract][Full Text] [Related]
11. The endometrium in asymptomatic breast cancer patients on tamoxifen: value of transvaginal ultrasonography with saline infusion and Doppler flow.
Develioğlu OH; Omak M; Bilgin T; Esmer A; Tüfekçi M
Gynecol Oncol; 2004 May; 93(2):328-35. PubMed ID: 15099941
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonographic evaluation of the endometrium in postmenopausal vaginal bleeding.
Davidson KG; Dubinsky TJ
Radiol Clin North Am; 2003 Jul; 41(4):769-80. PubMed ID: 12899491
[TBL] [Abstract][Full Text] [Related]
13. Uterine surveillance of asymptomatic postmenopausal women taking tamoxifen.
Gardner FJ; Konje JC; Brown L; Khanna S; Bell SC; Taylor DJ; al-Azzawi F
Climacteric; 1998 Sep; 1(3):180-7. PubMed ID: 11907942
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer.
Dibi RP; Zettler CG; Pessini SA; Ayub AV; de Almeida SB; da Silveira GP
Menopause; 2009; 16(2):293-300. PubMed ID: 19034048
[TBL] [Abstract][Full Text] [Related]
15. [Use of hysteroscopy, ultrasonography and selected hormonal tests for diagnosis of hyperplastic endometrial changes].
Bedner R
Ann Acad Med Stetin; 2001; 47():89-105. PubMed ID: 12514904
[TBL] [Abstract][Full Text] [Related]
16. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
17. The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen.
Schwartz LB; Snyder J; Horan C; Porges RF; Nachtigall LE; Goldstein SR
Ultrasound Obstet Gynecol; 1998 Jan; 11(1):48-53. PubMed ID: 9511196
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen.
Lee M; Piao J; Jeon MJ
Yonsei Med J; 2020 Apr; 61(4):317-322. PubMed ID: 32233174
[TBL] [Abstract][Full Text] [Related]
19. The value of transvaginal ultrasonography in the endometrial evaluation of breast cancer patients using tamoxifen.
Kazerooni T; Ghaffarpasand F; Mosalaei A; Kazerooni Y
Med Princ Pract; 2010; 19(3):222-7. PubMed ID: 20357508
[TBL] [Abstract][Full Text] [Related]
20. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data.
Duffy S; Jackson TL; Lansdown M; Philips K; Wells M; Pollard S; Clack G; Cuzick J; Coibion M; Bianco AR
BJOG; 2003 Dec; 110(12):1099-106. PubMed ID: 14664881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]